These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12049984)

  • 1. LC determination of piroxicam in human plasma.
    Dadashzadeh S; Vali AM; Rezagholi N
    J Pharm Biomed Anal; 2002 Jun; 28(6):1201-4. PubMed ID: 12049984
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioequivalence of two oral dosage forms prepared from different polymorphic modifications of tenoxicam.
    Salem MS; Alkaysi HN; Gharaibeh AM; Gharaibeh NM; Badwan AA
    J Clin Pharm Ther; 1994 Jun; 19(3):203-7. PubMed ID: 7962225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective method for the detection of piroxicam in human plasma using HPLC.
    Calvo AM; Prado MT; Dionísio TJ; Marques MP; Brozoski DT; Lanchote VL; Faria FA; Santos CF
    Braz Oral Res; 2016 May; 30(1):. PubMed ID: 27223141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of tenoxicam in rat.
    Raghavan CV; Abimon VD
    Int J Pharm; 2001 Jun; 221(1-2):227-9. PubMed ID: 11397584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of lornoxicam in human plasma by LC/MS/MS].
    Zeng YL; Chen XY; Zhang YF; Zhong DF
    Yao Xue Xue Bao; 2004 Feb; 39(2):132-5. PubMed ID: 15127622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
    Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
    Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction.
    Yritia M; Parra P; Fernández JM; Barbanoj JM
    J Chromatogr A; 1999 Jun; 846(1-2):199-205. PubMed ID: 10420612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography.
    Amanlou M; Dehpour AR
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):317-9. PubMed ID: 9323555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Pavlovian' food effect on the enterohepatic recirculation of piroxicam.
    Polli JE; Bigora S; Piscitelli DA; Straughn AB; Young D
    Biopharm Drug Dispos; 1996 Oct; 17(7):635-41. PubMed ID: 8894120
    [No Abstract]   [Full Text] [Related]  

  • 10. A rapid method for the determination of piroxicam in plasma by high-performance liquid chromatography.
    Maya MT; Pais JP; Morais JA
    J Pharm Biomed Anal; 1995 Mar; 13(3):319-22. PubMed ID: 7619893
    [No Abstract]   [Full Text] [Related]  

  • 11. Extractionless high-performance liquid chromatographic method for the simultaneous determination of piroxicam and 5'-hydroxypiroxicam in human plasma and urine.
    Avgerinos A; Axarlis S; Dragatsis J; Karidas T; Malamataris S
    J Chromatogr B Biomed Appl; 1995 Nov; 673(1):142-6. PubMed ID: 8925068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
    Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
    Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tenoxicam concentrations after single and multiple oral doses.
    Crevoisier C; Heizmann P; Forgo I; Dubach UC
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenoxicam: acute dose-dependent disposition studies in rats.
    Lopez-Bustamante LG; Troconiz JI; Fos D
    J Pharm Sci; 1993 Aug; 82(8):851-3. PubMed ID: 8377127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat.
    Heeb HL; Chun R; Koch DE; Moore L; Radlinsky M; Corse M; Pellerin MA; Garrett L; Hunter RP
    J Vet Pharmacol Ther; 2005 Oct; 28(5):447-52. PubMed ID: 16207307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam.
    Motawea A; Borg T; Tarshoby M; Abd El-Gawad AE
    Pharm Dev Technol; 2017 May; 22(3):445-456. PubMed ID: 27583581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HPLC determination of piroxicam in human serum and its pharmacokinetic parameters].
    Chen XL; Xi NZ; Ge SD; Sun SL
    Yao Xue Xue Bao; 1986 Sep; 21(9):692-7. PubMed ID: 3495096
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues.
    de Jager AD; Ellis H; Hundt HK; Swart KJ; Hundt AF
    J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):183-9. PubMed ID: 10410941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.